Article Information
History
- March 27, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Anthony Vladimir Campos Segura1,
- Sara Iolanda Oliveira da Silva1,
- Karina Miranda Santiago1,
- Rafael Canfield Brianese1,
- Dirce Maria Carraro1,2 and
- Giovana Tardin Torrezan1,2,*
- 1Clinical and Functional Genomics Group, A.C.Camargo Cancer Center, São Paulo, Brazil
- 2National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, São Paulo, Brazil
- ↵*Corresponding author: Giovana Tardin Torrezan, Clinical and Functional Genomics Group, International Research Center/CIPE, A.C.Camargo Cancer Center, Mailing address: 440 Taguá St., Sao Paulo, SP, 01508-010 Brazil., giovana.torrezan{at}accamargo.org.br
Authors contribution: Conceptualization: G.T.T.; Formal analysis: A.V.C.S., S.I.O.S., K.M.S, R.C.B., D.M.C. and G.T.T; Methodology: A.V.C.S. and S.I.O.S., Investigation: A.V.C.S., S.I.O.S., K.M.S, R.C.B., and G.T.T; Funding acquisition: D.M.C. and G.T.T., Supervision: G.T.T.; Resources: D.M.C. and G.T.T., Writing—original draft preparation: A.V.C.S. and G.T.T.; Writing—review and editing: A.V.C.S., S.I.O.S., K.M.S, R.C.B., D.M.C. and G.T.T. All authors have read and agreed to the published version of the manuscript.